Wexford Science + Technology announced last week it has launched its own venture fund focused on investing in early and late-stage seed opportunities, as well as its first two investments through the fund. Named the SciTech Venture Fund, this new initiative for Wexford “aims to partner with university and regional funds to provide startups with the financial support, connections and resources they need to grow and thrive.” The fund will initially focus on life science and technology companies in one of the 17 markets where Wexford Science + Technology already operates, including Phoenix, according to a press release.Continue reading
Author Archive: AZBio
Midwestern AZ Health Careers Program – Summer 2023
The 2023 Health Careers Institute for high school students is a free educational opportunity for high school sophomores, juniors, and seniors to explore a variety of health professions.
Sixty-four high school sophomores, juniors, and seniors will be selected through an application process. Applications can be submitted via Google Forms starting January 1 and are due April 1.Continue reading
GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare
Financing Will Help Expand Access to GammaTile® Therapy for Patients with Newly Diagnosed and Recurrent Brain TumorsContinue reading
The American Diabetes Association and Genentech Partner to Increase Equitable Access to Eye Health Care
Project Aims to Remove Barriers to Care to Help Prevent Vision LossContinue reading
Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study
Study data shows consistent independent risk stratification performance of DecisionDx-SCC in a novel cohort of patients with cutaneous squamous cell carcinoma and one or more risk factorsContinue reading
Support Health Innovators and Patient Champions on Arizona Gives Day
Community nonprofits are asking for your support as part of Arizona Gives. Early giving has begun and will continue through #AZGivesDay on April 4, 2023. Arizona Gives is powered by Alliance of Arizona Nonprofits + Arizona Grantmakers Forum.Continue reading
BeScreened Blood-based Colorectal Cancer Test Provides Affordable Early detection Without the Mess
Beacon Biomedical’s BeScreened-CRC blood test improves screening compliance and therefore the probability of survival while dramatically reducing the cost of treatment of CRC without the need for fecal collection.Continue reading
GT Medical Technologies Names Dr. Michael A. Garcia as Chief Medical Officer
TEMPE, Ariz., March 16, 2023—GT Medical Technologies, Inc. has appointed Michael A. Garcia, MD, MS, as its Chief Medical Officer.
In his new role, Dr. Garcia will expand the GammaTile® Therapy clinical study pipeline, support research and development, lead medical affairs, and promote additional efforts for expanding the evidence-based use of GammaTile Therapy and its incorporation into oncology care guidelines. Continue reading
New Virtual Education Program for Cancer Caregivers Launches
The new Virtual Cancer Caregivers Education Program provides online education and resources to Cancer Caregivers delivering the information they need when they need it.
The program will launch March 25, 2023 at the MMRF/AzMN Patient and All Cancer Caregivers’ Summit in Scottsdale.
ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Performance and Medical Device Development
- A $996,413 Phase II SBIR grant from the NSF advances ReSuture’s efforts to quantify operative performance through simulated surgical platforms, capacitive sensing, and machine learning
- ReSuture’s proposed technology – a combination of lifelike physical simulations, novel sensors, and robust data analysis – is addressing a universal market need that has been unsolved for decades
- ReSuture’s early working solutions have been adopted by device manufacturers W.L. Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic